Skip to content
Wearables & measurementCross-sectional study3 min read

Wrist-sensor sleep differences appear across psychiatric diagnoses, with small effects

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Association of accelerometer-derived sleep measures with lifetime psychiatric diagnoses: A cross-sectional study of 89,205 participants from the UK Biobank. · PLoS medicine · 2021 · Original paper ↗

Key takeaway

Among 89,205 UK Biobank participants, those with a lifetime inpatient psychiatric diagnosis differed from others on a median of 8.5 of 10 wrist-accelerometer sleep measures, but effects were small (largest beta -0.11, 95% CI -0.13 to -0.10, for depression and sleep efficiency). This is cross-sectional, and diagnoses often came before the sleep recording.

Study design

Cross-sectional study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Sleep problems are both symptoms of and risk factors for many psychiatric disorders, and wrist accelerometers can measure sleep objectively in very large groups. The authors tested how accelerometer-derived sleep measures relate to psychiatric diagnoses and to genetic risk scores.

Who and how

Post hoc cross-sectional analysis of the UK Biobank. Ten sleep measures (bedtime, wake-up time, sleep duration, wake after sleep onset, sleep efficiency, number of awakenings, longest sleep bout, number of naps, and variability in bedtime and sleep duration) were derived from 7-day accelerometer recordings in 89,205 participants aged 43 to 79 (56% female, 97% self-reported white) taken between 2013 and 2015. They were compared with lifetime inpatient diagnoses of major depressive disorder, anxiety disorders, bipolar disorder/mania and schizophrenia spectrum disorders, and with polygenic risk scores for depression, bipolar disorder and schizophrenia. Models adjusted for age, season, sex, Townsend deprivation index and 10 genotype principal components.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Sleep differences were widespread: each diagnosis was associated with a median of 8.5 of the 10 sleep measures.
  2. 2
    Measures of sleep quality, such as sleep efficiency, were generally more affected than sleep duration alone.
  3. 3
    Effects were small. The largest was beta = -0.11 (95% CI -0.13 to -0.10; p = 3 × 10-56) for lifetime inpatient major depressive disorder and sleep efficiency.
  4. 4
    Associations largely replicated across ancestries and sexes, and accelerometer measures agreed with self-reported sleep.

Limits & uncertainty

  1. 1
    Accelerometer-based sleep estimates infer sleep from movement, which the authors list as a limitation.
  2. 2
    There was a time lag between psychiatric diagnoses and the accelerometer recording, so sleep at diagnosis is not measured.
  3. 3
    Cross-sectional, post hoc analysis, so direction of effect is unknown; the sample is 97% self-reported white and only inpatient diagnoses were counted.
  4. 4
    This reading is based on the abstract only.

What to take from it

Sleep differences, especially in sleep quality rather than just duration, accompanied psychiatric diagnoses across the board, but each difference was small. Having a given sleep pattern does not mean you have, or will develop, a psychiatric condition. Concerns about mood or sleep should be discussed with a clinician.

Reading your own data

Wrist wearables report similar measures such as sleep efficiency, awakenings, bedtime and its variability. Use the same device and compare your own multi-week averages, especially bedtime regularity, and don't read much into one night or into small differences.

How to read this evidence

Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Sleep problems are both symptoms of and modifiable risk factors for many psychiatric disorders. Wrist-worn accelerometers enable objective measurement of sleep at scale. Here, we aimed to examine the association of accelerometer-derived sleep measures with psychiatric diagnoses and polygenic risk scores in a large community-based cohort.

Methods and findings

In this post hoc cross-sectional analysis of the UK Biobank cohort, 10 interpretable sleep measures-bedtime, wake-up time, sleep duration, wake after sleep onset, sleep efficiency, number of awakenings, duration of longest sleep bout, number of naps, and variability in bedtime and sleep duration-were derived from 7-day accelerometry recordings across 89,205 participants (aged 43 to 79, 56% female, 97% self-reported white) taken between 2013 and 2015. These measures were examined for association with lifetime inpatient diagnoses of major depressive disorder, anxiety disorders, bipolar disorder/mania, and schizophrenia spectrum disorders from any time before the date of accelerometry, as well as polygenic risk scores for major depression, bipolar disorder, and schizophrenia. Covariates consisted of age and season at the time of the accelerometry recording, sex, Townsend deprivation index (an indicator of socioeconomic status), and the top 10 genotype principal components. We found that sleep pattern differences were ubiquitous across diagnoses: each diagnosis was associated with a median of 8.5 of the 10 accelerometer-derived sleep measures, with measures of sleep quality (for instance, sleep efficiency) generally more affected than mere sleep duration. Effect sizes were generally small: for instance, the largest magnitude effect size across the 4 diagnoses was β = -0.11 (95% confidence interval -0.13 to -0.10, p = 3 × 10-56, FDR = 6 × 10-55) for the association between lifetime inpatient major depressive disorder diagnosis and sleep efficiency. Associations largely replicated across ancestries and sexes, and accelerometry-derived measures were concordant with self-reported sleep properties. Limitations include the use of accelerometer-based sleep measurement and the time lag between psychiatric diagnoses and accelerometry.

Conclusions

In this study, we observed that sleep pattern differences are a transdiagnostic feature of individuals with lifetime mental illness, suggesting that they should be considered regardless of diagnosis. Accelerometry provides a scalable way to objectively measure sleep properties in psychiatric clinical research and practice, even across tens of thousands of individuals.

Sources & attribution

Association of accelerometer-derived sleep measures with lifetime psychiatric diagnoses: A cross-sectional study of 89,205 participants from the UK Biobank.

Wainberg M, Jones SE, Beaupre LM, Hill SL, Felsky D, Rivas MA, Lim ASP, Ollila HM, Tripathy SJ.

PLoS medicine · 2021-10-12

DOI: 10.1371/journal.pmed.1003782 ↗PubMed · 34637446 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →